Andreas Halvorsen's LAB Position Overview
Andreas Halvorsen (via Viking Global Investors Lp) currently holds 58.65 M shares of Standard BioTools Inc. (LAB) worth $76.25 M, representing 0.20% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 7 quarters.
Based on 13F filings, Andreas Halvorsen has maintained this position in LAB for several quarters, showing initial confidence in the investment.
Analysis based on 13F filings available since 2013 Q2
Andreas Halvorsen's Standard BioTools (LAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Standard BioTools (LAB) Trades by Andreas Halvorsen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2024 | +58.65 M | New Buy | 58.65 M | $2.71 |
Andreas Halvorsen's Standard BioTools Investment FAQs
Andreas Halvorsen first purchased Standard BioTools Inc. (LAB) in Q1 2024, acquiring 58,651,170 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Andreas Halvorsen has held Standard BioTools Inc. (LAB) for 7 quarters since Q1 2024.
Andreas Halvorsen's largest addition to Standard BioTools Inc. (LAB) was in Q1 2024, adding 58,651,170 shares worth $158.94 M.
According to the latest 13F filing for Q3 2025, Andreas Halvorsen's firm, Viking Global Investors Lp, owns 58,651,170 shares of Standard BioTools Inc. (LAB), valued at approximately $76.25 M.
As of the Q3 2025 filing, Standard BioTools Inc. (LAB) represents approximately 0.20% of Andreas Halvorsen's publicly disclosed stock portfolio, making it one of their key holdings.
Andreas Halvorsen's peak holding in Standard BioTools Inc. (LAB) was 58,651,170 shares, as reported at the end of Q1 2024.